Benefit Co. Catamaran Inks $410M Rival Buy As Earnings Soar
Pharmacy benefit manager Catamaran Corp. will put up $409.5 million to absorb Restat LLC, one of its biggest privately owned rivals, to build up its client base and expand its core...To view the full article, register now.
Already a subscriber? Click here to view full article